Apollo Endosurgery Operating Income

As of the most recent data (December 2022), APEN shows a operating income of $-28M. That compares with $-20M in the prior-year period — down 41.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APEN's operating income is now $-28M (was $-20M) — a 41.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Apollo Endosurgery is outperforming or lagging.

Tracking APEN's operating income over time shows whether Apollo Endosurgery is scaling, shrinking, or reshaping that part of the business. The current reading is $-28M That compares with $-20M in the prior-year period — down 41.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Apollo Endosurgery's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-28M) with ownership activity and broader fundamentals.

Apollo Endosurgery's operating income is $-28M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.